- Lindab’s net sales for the fourth quarter were SEK 3.31 billion, falling short of the estimated SEK 3.4 billion.
- In 2024, Lindab recorded its highest sales ever, primarily due to completed acquisitions.
- Despite strong annual sales, the company faced challenges towards the end of the year with low sales volumes and an unfavourable product mix.
- The fourth-quarter results were lower than expected due to continued negative organic growth and an unexpectedly weak performance in December.
- The weak economic environment in 2024 led to negative organic growth in several major markets, including Germany, France, and Sweden.
- Lindab’s stock is currently rated with three buys, three holds, and no sells.
“`
A look at Lindab International Ab Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have assessed Lindab International AB’s long-term outlook using the Smart Scores system. The company has received a solid score of 4 for both Dividend and Growth prospects, indicating a positive outlook on potential dividend payouts and future growth opportunities. Lindab International AB’s ability to maintain steady dividends and sustain growth in its market are seen as strengths by analysts.
While the company received slightly lower scores in Value (3), Resilience (3), and Momentum (2), the overall picture for Lindab International AB remains optimistic. With a focus on developing, manufacturing, and marketing sheet metal products for the ventilation and construction industry, the company’s position in the market and growth potential are positively evaluated by analysts using the Smart Scores system.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
